Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C, Keeratichamroen S, Sritana N, Kantathavorn N, Diskul-Na-Ayudthaya P, Saharat K, Chantaraamporn N, Verathamjamras C, Phoolcharoen N, Wiriyaukaradecha K, Paricharttanakul NM, Udomchaiprasertkul W, Sricharunrat T, Auewarakul C, Svasti J. and Srisomsap C*. Oncol Lett. 2019 Jun;17(6):5453-5468.

01 Jun 2019
0

Urinary biomarkers for the diagnosis of cervical cancer by quantitative label-free mass spectrometry analysis. 

Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P, Weeraphan C,  Keeratichamroen S, Sritana N, Kantathavorn N, Diskul-Na-Ayudthaya P, Saharat K, Chantaraamporn N, Verathamjamras C, Phoolcharoen N, Wiriyaukaradecha K, Paricharttanakul NM, Udomchaiprasertkul W, Sricharunrat T, Auewarakul C, Svasti J. and Srisomsap C*. 

Oncol Lett. 2019 Jun;17(6):5453-5468.

Tags

Share this

Related Posts

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study.  Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C.  Molecules. 2022 Sep;27(18):5904.

Recent Posts